Am J Transplant, Volume 17, Suppl 3 Archives - Page 181 of 181 - ATC Abstracts

2017 American Transplant Congress
Measurement of Dissolved Oxygen by ¹⁹F MRI of Microcapsules Implanted IP in Non-Human Primates.
S. Safley,¹ M. Graham,² M. Garwood,³ K. Papas,⁵ B. Weegman,^3,4 G. Barber,¹ E. Lin,¹ J. Leisen,⁷ A. Sambanis,⁶ B. Hering,² C. Weber.¹
¹Surgery, Emory University, Atlanta, GA; ²Surgery, University of Minnesota, Minneapolis, MN; ³Radiology, University of Minnesota, Minneapolis, MN; ⁴Sylvatica Biotech, Inc., Charleston, SC; ⁵Surgery, University of Arizona, Tucson, AZ; ⁶School of Chemical and Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA; ⁷School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA
Since our encapsulated NHP islet allografts and porcine islet xenografts fail after i.p. transplantation in immunosuppressed NHPs without a cellular or humoral immune response, we…
2017 American Transplant Congress
Graft Loss from Anti-GBM Nephritis: A Rare Event in Alport Syndrome, Even with a Severe COL4A5/A4/A3 Mutation.
V. Gillion,¹ K. Dahan,² E. Goffin,¹ J.-P. Cosyns,³ M. Jadoul,¹ M. De Meyer,⁴ M. Mourad,⁴ Y. Pirson,¹ N. Kanaan.¹
¹Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; ²Génétique Humaine, Institut de Pathologie et de Génetique, Gosselies, Belgium; ³Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; ⁴Surgery and Abdominal Transplantation, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Background: Alport syndrome (AS) is caused by mutations in α3/α4/α5 (IV) collagen genes, whose severity determines the progression of AS. Post-transplant outcome is good, though…
2017 American Transplant Congress
Continuation of Immunosuppression Appears to Protect Against Allosensitization in Patients Listed for a Second Kidney Transplant.
S. Kuppachi,¹ M. Sanders,¹ R. Kalil,¹ Z. Stewart,² C. Thomas.¹
¹Internal Medicine, University of Iowa, Iowa City, IA; ²Transplant Surgery, University of Iowa, Iowa City, IA
Purpose: The current standard of practice after allograft loss is to discontinue immunosuppression (IS) to decrease complications related to prolonged exposure. There is a paucity…
2017 American Transplant Congress
De Novo Malignancy Occurrence After Kidney Transplantation in HLA-Sensitized Patients Treated with B-Cell Targeting Therapy.
L. Couzi,^1,2,3 P. Davis,¹ J. Visentin,^1,2,3 B. Taton,¹ G. Guidicelli,¹ H. Kaminski,^1,2,3 P. Merville,^1,2,3 T. Bachelet.⁴
¹CHU de Bordeaux, Bordeaux, France; ²Université de Bordeaux, Bordeaux, France; ³UMR CNRS 5164 Immunoconcept, Bordeaux, France; ⁴Clinique Saint-Augustin-CTMR, Bordeaux, France
Management of high risk transplantations in patients with preformed DSA still remains a dilemma. Many groups propose to increase the immunosuppression in these patients by…
2017 American Transplant Congress
Impact of Inflammatory Bowel Disease on Survival and Risk of Retransplantation of Primary Sclerosing Cholangitis Patients Following Liver Transplantation: UNOS Data Analysis.
O. Mousa,¹ N. Patel,¹ J. Corral,¹ D. Lee,² J. Nguyen,² K. Croome,² D. Harnois.²
¹Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL; ²Transplant, Mayo Clinic, Jacksonville, FL
Background: The impact of inflammatory bowel disease (IBD) on outcomes after liver transplantation (LT) for primary sclerosing cholangitis (PSC) has been inconclusive. Previous reports suggested…
2017 American Transplant Congress
Effective Thrombolytic Therapy of Hepatic Artery Thrombosis After Liver Transplantation – A Single-Center Experience.
M. Chen,¹ X. Lin,² W. Ju,¹ D. Wang,¹ Y. Ma,¹ L. Wu,¹ X. He,¹ G. Chen.¹
¹Organ Transplant Center, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China; ²Department of Thyroid and Breast Surgery, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
BACKGROUND: Hepatic artery thrombosis (HAT) is a common complication of liver transplantation which causes lots of graft loss. The anastomoses of hepatic artery requires delicate…